However, the same study showed that HIF-1α inhibition could decrease chemoresistance in diabetic breast cancer patients [45], the used inhibitor was PX-478 which presented only some specificity to the HIF-1α isoform [110]. This evidence concerns the gene HIF1A and breast cancer.